- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03888599
Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination
September 25, 2019 updated by: Jeannot Emilien, University Hospital, Geneva
Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination Among Undergraduate Health Students From Switzerland
A better understanding of the target audiences about HPV infection and HPV vaccination would surely allow for a better spread of this vaccination in Switzerland.
In order to know if the target audiences are properly informed, we have decided to carry out a study evaluating their level of knowledge on a particular audience that are the men and women undergraduate nurse.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
600
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Geneva, Switzerland
- Jeannot
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 36 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Men and women above the age of 18 years, currently attending the School of Health Sciences of three selected Swiss towns to obtain a nurse or midwife degree
Description
Inclusion Criteria:
- Eligible women and men aged between 18-36 years
- Understands study procedures and accepts voluntarily to participle of the study
Exclusion Criteria:
.Don't understand french language
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Questionnaire about basic knowledge HPV infection
Time Frame: 3 months
|
Percentage of right answer of the questionnaire
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2019
Primary Completion (Actual)
June 1, 2019
Study Completion (Actual)
August 1, 2019
Study Registration Dates
First Submitted
March 14, 2019
First Submitted That Met QC Criteria
March 21, 2019
First Posted (Actual)
March 25, 2019
Study Record Updates
Last Update Posted (Actual)
September 26, 2019
Last Update Submitted That Met QC Criteria
September 25, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Req-2019-00118
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HPV-Related Cervical Carcinoma
-
Global Alliance to Immunize Against AIDS Vaccine...Merck Sharp & Dohme LLCCompletedHPV-Related Cervical Carcinoma | HPV
-
University of PennsylvaniaCompletedHPV-Related Cervical CarcinomaUnited States
-
TransgenePfizer; EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt...Active, not recruitingHPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV-Related Anal Squamous Cell Carcinoma | HPV-Related Penile Squamous Cell Carcinoma | HPV-Related Vulvar Squamous Cell CarcinomaUnited States, France, Spain
-
Dr. Faizan AwanCompletedHPV-Related Cervical Carcinoma | Physician-Patient RelationsUnited Kingdom
-
TScan Therapeutics, Inc.RecruitingMelanoma | Cervical Cancer | Head and Neck Cancer | HPV-Related Malignancy | Ovarian Cancer | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Non-small Cell Carcinoma | HPV - Anogenital Human Papilloma Virus Infection | HPV-Related Adenocarcinoma | HPV-Related Adenosquamous Carcinoma and other conditionsUnited States
-
National Vaccine and Serum Institute, ChinaGuangxi Center for Disease Control and Prevention; Simoon Record Pharma Information... and other collaboratorsCompletedHPV Infection | HPV-Related Cervical CarcinomaChina
-
National Vaccine and Serum Institute, ChinaGuangxi Center for Disease Control and Prevention; Simoon Record Pharma Information... and other collaboratorsCompleted
-
Christian HinrichsRecruitingCervical Cancer | HPV-Related Malignancy | Metastatic Cancer | Anal Cancer | Oropharynx Cancer | Vaginal Cancer | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Penile Cancer | HPV-Related Adenocarcinoma | HPV-Related Adenosquamous Carcinoma | HPV-Related... and other conditionsUnited States
-
Christian HinrichsNational Cancer Institute (NCI)Not yet recruitingCervical Cancer | HPV-Related Malignancy | Vulvar Cancer | Anal Cancer | Oropharynx Cancer | Vaginal Cancer | HPV-Related Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Penile Cancer | HPV-Associated Cervical Carcinoma | HPV-Related Adenocarcinoma | HPV-Related Adenosquamous Carcinoma | HPV-Related... and other conditionsUnited States
-
Instituto Nacional de Salud Publica, MexicoCompletedFASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program (FASTER)Cervical Intraepithelial Neoplasia | HPV-Related Cervical CarcinomaMexico
Clinical Trials on knowledge questioannaire
-
Sunnybrook Health Sciences CentreScarborough General Hospital; Michael Garron Hospital; York Central Hospital,... and other collaboratorsCompleted
-
Swiss Tropical & Public Health InstituteWorld BankActive, not recruitingCompliant Behavior | Morbidity;InfantSwitzerland, Congo, The Democratic Republic of the
-
Hatice Yüceler KaçmazCompletedKnowledge, Attitudes, Practice | Wound | Nurse's RoleTurkey
-
Jonathan SinclairCompleted
-
Rutgers UniversityKessler Institute for RehabilitationCompleted
-
Dalarna County Council, SwedenCompletedKnowledge, Attitudes, Practice | Oral Health | AttitudeSweden
-
HealthPartners InstituteCompleted
-
Montreal General HospitalSanofi; Canadian Institutes of Health Research (CIHR); Fonds de la Recherche...CompletedAcute Coronary Syndromes
-
University of PisaNational Health and Medical Research Council, Australia; European CommissionEnrolling by invitation
-
Cairo UniversityNot yet recruiting